In contrast, CCL2 was overexpressed in lupus nephritis (p < 0.0001, Fold Change: 2.294), diabetic nephropathy (p < 0.0001, Fold Change: 3.466), focal segmental glomerulosclerosis (p < 0.01, Fold Change: 3.171), and minimal change disease (p > 0.05) (Figures 8B–E). This evidence concerns the gene CCL2 and focal segmental glomerulosclerosis.